Patents by Inventor Jan BLUMENSTEIN

Jan BLUMENSTEIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition For Prevention of Vasoactivity in the Treatment of Blood Loss and Anemia
    Publication number: 20160206623
    Abstract: The present invention relates to the prevention of cardiovascular and central nervous system side effects in mammals who receive transfusions of hemoglobin based oxygen carriers (HBOC) or stored blood products containing a concentration of hemoglobin sufficient to induce vasoconstriction, by adding a vasoactivity reducing effective amount of one or more phosphodiesterase inhibitors in combination with a calcium channel blocker and/or an alpha agonist, to the circulation, or alternatively to the HBOC or stored blood, thereby preventing the manifestation of vasoactivity attributable to the presence of free tetrameric hemoglobin (Hb).
    Type: Application
    Filed: April 14, 2014
    Publication date: July 21, 2016
    Inventor: Jan BLUMENSTEIN
  • Composition For Prevention of Vasoactivity in the Treatment of Blood Loss and Anemia
    Publication number: 20150290213
    Abstract: The present invention relates to the prevention of cardiovascular and central nervous system side effects in mammals who receive transfusions of hemoglobin based oxygen carriers (HBOC) or stored blood products containing a concentration of hemoglobin sufficient to induce vasoconstriction, by adding a vasoactivity reducing effective amount of one or more phosphodiesterase inhibitors in combination with a calcium channel blocker and/or an alpha agonist, to the circulation, or alternatively to the HBOC or stored blood, thereby preventing the manifestation of vasoactivity attributable to the presence of free tetrameric hemoglobin (Hb).
    Type: Application
    Filed: April 14, 2014
    Publication date: October 15, 2015
    Inventor: Jan BLUMENSTEIN
  • Composition For Prevention of Vasoactivity in the Treatment of Blood Loss and Anemia
    Publication number: 20130274245
    Abstract: The present invention relates to the prevention of cardiovascular and central nervous system side effects in mammals who receive transfusions of hemoglobin based oxygen carriers (HBOC) or stored blood products containing a concentration of hemoglobin sufficient to induce vasoconstriction, by adding a vasoactivity reducing effective amount of one or more phosphodiesterase inhibitors in combination with a calcium channel blocker and/or an alpha agonist, to the circulation, or alternatively to the HBOC or stored blood, thereby preventing the manifestation of vasoactivity attributable to the presence of free tetrameric hemoglobin (Hb).
    Type: Application
    Filed: March 12, 2013
    Publication date: October 17, 2013
    Inventor: Jan BLUMENSTEIN